Fosun Pharma's 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public

On March 27, 2023, the release date of its 2022 Annual Report, Fosun Pharma also released the "2022 Corporate Social Responsibility Report," its 15thCSR report since the first which... | March 30, 2023

Related Keywords

Jada Yuan ,Guangdong ,China ,Chinese ,Fosun Pharma ,Han Li Kang ,Fosun Health ,Fosun Pharma Health Care Initiative ,Better Health For Families Worldwide ,National Medical Insurance Drug Catalogue ,Fund For Fosun Pharma Health Care Initiative ,Rating Expert Committee ,Fosun Foundation ,Fosun Foundation Shanghai ,Innovation For Good Health ,Social Responsibility Report ,Corporate Social Responsibility ,Daily Online ,Fortune China ,Corporate Social Responsibility Report ,Rituximab Injection ,Avatrombopag Maleate Tablets ,Adalimumab Injection ,Axicabtagene Ciloleucel Injection ,Palonosetron Capsules ,Apremilast Tablets ,Responsibility Path ,Medicines Patent Pool ,Fosun Pharma Operation Excellence ,Pharma Health Care ,Genuine Biotech ,Special Fund ,Fosun Pharma Health Care ,Shanghai Fosun Pharmaceutical Group Co ,Td Stock Exchange ,News ,Information ,Press Release ,N ,Arch ,The ,Release ,Gate ,F ,Its ,022 ,Nnual ,Osun ,Dharma ,Also ,Eleased ,Corporate ,Ocial ,Responsibility ,5thcsr ,Report ,Rince ,Irst 600196 Cne000000x38 ,